Nano-Monitoring of Cancer Immunotherapy Efficiency: The Graphene Lateral Electrophoretic Bioassay platform (GLEBIOASSAY)

Reference: AC21_2/00044 Funded by: Instituto de Salud Carlos III and European Union Next Generation EU / PRTR Period: 01/01/2022 – 31/12/2024 Partners: Fundació Privada per a la Recerca i la Docència Sant Joan de Déu (FSJD) (Spain), Nehir Biyoteknoloji Ltd. (NehitBT) (Turkey), Palacký University Olomouc (UP) (Czech Republic) Summary: GLEBioassay...

Polymerase Amplification combined into a Paper-based electrochemical lateral flow arraY for antimicrobial Resistance qUantification (PAPYRUs))

Reference: PLEC2021-007972 Funded by: MCIN / AEI / 10.13039/501100011033 and European Union Next Generation EU / PRTR Period: 01/11/2021 – 31/10/2024 Partners: Fundación Pública Andaluza para la Gestió de la Investigación en Salud de Sevilla (Spain), Paperdrop Dx (Spain) Summary: In the PAPYRUs project we aim to prototype...

Emerging Printed Electronics Research Infrastructure (EMERGE)

Reference: 101008701 Funded by: European Commission Period: 01/07/2021 – 30/06/2025 https://emerge-infrastructure.eu/   Partners: : UNINOVA-INSTITUTO DE DESENVOLVIMENTO DE NOVAS TECNOLOGIAS-ASSOCIACAO (Portugal), ELLINIKO MESOGEIAKO PANEPISTIMIO (Greece), POLITECHNIKA WARSZAWSKA (Poland), FORSCHUNGSZENTRUM JULICH GMBH (Germany),...

Real-time sensing of diagnostically relevant biomarkers in urine for the Monitoring of Acute Kidney Injury (2) – (MAKI-2)

Funded by: BIST Period: 01/01/2022 – 31/12/2022   Partners: Fundació Institut Català de Nanociència i Nanotecnologia (ICN2) and Institut Català d’Investigació Química (ICIQ) Summary: The second phase of MAKI-2 will allow us to continue improving the binding studies in the solid-liquid interface and to test the...

Multiplexed nanobiosensor for the instantaneous diagnosis and classification of anaemia at the point of care (NANOANAEMIA)

Reference: PLEC2021-007727 Funded by: MCIN / AEI / 10.13039/501100011033 and European Union Next Generation EU / PRTR Period: 01/12/2021 – 30/11/2024 Partners: BLOODGENETICS, S.L. (Spain), Universitat Internacional de Catalunya, Fundació Privada (Spain) NANOANAEMIA is a collaborative project between the Merkoçi at ICN2 (coordinator),...

Graphene Flagship Core 3

Reference: 785219 Funded by: European Commission Period: 01/04/2020 – 31/03/2023           Partners: Coordinated by CHALMERS TEKNISKA HOEGSKOLA AB (Sweeden) and with the participation of 177 partners. The Graphene Flagship is a Future and Emerging Technology Flagship by the European Commission. With...

Real-time sensing of diagnostically-relevant biomarkers in urine for the monitoring of acute kidney injury (MAKI)

Funded by: BIST Period: 04/03/2020 – 21/02/2021   Partners: Fundació Institut Català de Nanociència i Nanotecnologia (ICN2) and Institut Català d’Investigació Química (ICIQ) Summary: Acute renal failure (ARI) is a common complication in major surgeries, and until recently its detection was based on a single biomarker,...

Graphene Flagship Core 2

Reference: 785219 Funded by: European Commission Period: 01/04/2018 – 31/03/2020         Partners: Coordinated by CHALMERS TEKNISKA HOEGSKOLA AB (Sweeden) and with the participation of 177 partners. Summary: The Graphene Flagship is a Future and Emerging Technology Flagship by the European Commission. With...

MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response (MICROB-PREDICT)

Reference: 825694 Funded by: European Commission Period: 01/01/2019 – 31/03/2025         Partners: EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF) (Spain), DEBRECENI EGYETEM (Hungary), ODENSE UNIVERSITETSHOSPITAL (Denmark), KOBENHAVNS UNIVERSITET (Denmark), EUROPEAN MOLECULAR BIOLOGY...

Integrated smart cost and effective nanodiagnostics (INCOSTNANO)

Reference: MAT2017-87202-P Funded by: MINECO (Spanish Government) Period: 01/01/2018 – 31/12/2021 Partners: Fundació Institut Català de Nanociència i Nanotecnologia.   Summary: In the last years the development of new biosensors has increased significantly, especially in diagnostics, since it has been shown that an...